top of page
Image by Diego PH

What can we do for you?

Global business consulting firm specializing in strategic business development, technology commercialization, financing, licensing, and partnership activities.

scroll

Strategic partnership

Prescient Venture Development offers a range of services to support clients with their asset, technology, and product in/out-licensing activities across North America, SE Asia, and Europe. Our experienced team can assist with defining and negotiating the terms of the deal, providing strategic advice, and managing the entire licensing process from start to finish.

  • Assist with licensing, acquisition, joint partnership, alliance and divestiture activities.

  • Assets and product portfolio analysis 

  • Assets opportunities for search and identification of potential global partners.

  • Support for in-licensing/out-licensing process and project management

  • Assistance with deal negotiation process and contractual phase

  • Strategic advice

Investment & Capital Raising

Prescient Venture Development provides a range of services to assist clients in achieving their business objectives, including:

  • Due diligence support to ensure informed decision-making

  • Seed and early-stage capital raising services to secure funding

  • Philanthropy and grant funding support to promote social impact

  • Strategic investment guidance for optimal growth and profitability

  • Venture and pre-IPO capitalization services to prepare for public listing.

New Venture Launch & Expansion

We provide comprehensive services to support the development and launch of new ventures, including:

  • New venture start-up planning and development

  • Strategic business and marketing plan development

  • Project planning and execution

  • Product and technology development and commercialization advice.

Cross-border Product Launch & Operation

We provide comprehensive support to our clients in navigating the requirements and nuances of various regional biomedical markets.

Our services include:

  • Market entry strategy development for Asia, North America, and Europe

  • Assistance with international distribution and operations activities

  • Product registration and regulatory guidance

  • Market prioritization and distributor selection

  • Identification of competitors and potential collaborators, as well as barriers to entry

  • Introduction of products or technologies to potential export partners

  • Facilitation of partnership discussions with prospective allies

  • Support with negotiating distribution, licensing, or commercial supply agreements.

Image by JESHOOTS.COM

Other Services

We have a wide-ranging network of contacts and global partners that we can leverage to match our clients' objectives. Our services include:

  • Screening and recruiting qualified key experts, advisors, and board members

  • Strategic and tactical planning

  • Assistance with product registration and regulatory compliance

  • Support for CRO and clinical trials

  • Investment and technology due diligence

  • Scientific and technical advice

Pharma Business Development & Asset Scouting

We offer pharma business development services and asset scouting to assist companies and investors in discovering new opportunities. Our team works collaboratively with our clients to maximize their effectiveness and achieve their goals.

In- licensing & Out- licensing

In-licensing involves pharmaceutical and biotechnology companies with capital and resources searching for new technologies and products for their internal pipeline, as well as VC's, investors, and entrepreneurs seeking to build companies around new products and technologies.

 

Out-licensing, on the other hand, involves finding partners for technologies that do not fit with a company's mission or low-priority technologies. Types of out-licensing include universities, research institutes, and other for- and non-profit research centers, as well as small to medium biotechnology companies seeking capital, resources, and risk/reward sharing. Additionally, biotech-big pharma alliances are common in the industry.

bottom of page